Next-Generation Regenerative Medicine
Now available at BHRC: the ultimate longevity protocol delivering the “end product” of regeneration—a clinically engineered, DNA-free foundation designed to reset cellular receptors and restore signaling precision.
Understanding Cell Factor
Cell Factor delivers the “end product” of regeneration—not the factory that makes it. Unlike live-cell therapies that introduce biological complexity, variability, and immunogenic risk, Cell Factor is a clinically engineered, DNA-free formulation that provides isolated signaling factors with standardized potency across every batch.
Traditional stem cell therapies are “the factory”—living cells with donor-dependent composition, regulatory classification as drugs or biologics, and inherent cellular variability. Cell Factor is “the product”—a non-cellular, shelf-stable foundation that resets cellular receptors and restores signaling precision without the complications of live biology.
This approach delivers over 400 growth factors and extracellular vesicles (EVs) that optimize cellular communication pathways. By clearing inflammatory noise and re-establishing receptor sensitivity, Cell Factor creates an environment where your body’s repair mechanisms—and any additional therapies—can function at peak efficiency.
Published research in Biomolecules (2024) confirms that acellular therapies provide “comparable regenerative potential” to stem cell-based therapies while avoiding limitations like tumor formation risk, immune rejection, and complex regulatory hurdles. Cell Factor holds FDA Section 361 tissue classification—not classified as a drug—with minimal immunogenic profile.
At BHRC, we integrate Cell Factor across our aesthetic and wellness treatments to amplify results and accelerate healing. Whether combined with microneedling, laser therapy, IV nutrients, or administered as standalone therapy, Cell Factor represents the next evolution in regenerative aesthetics.
Why We Offer Cell Factor
Experience regenerative aesthetics that’s safer, more powerful, and backed by peer-reviewed clinical research.
Acellular technology eliminates risks of tumor formation, immune rejection, and DNA alterations—delivering therapeutic benefits without living cells.
Delivers 400+ growth factors compared to PRP’s 7-25, providing a higher concentration and diversity of bioactive molecules for enhanced results.
Nanoscale delivery (30-150 nm) enables deep tissue penetration, blood-brain barrier crossing, and superior cellular uptake compared to cellular therapies.
Backed by 77 registered clinical trials worldwide, with peer-reviewed studies demonstrating efficacy in hair restoration, skin rejuvenation, and joint therapy.
Classified as human tissue, not a drug or biologic. Minimal immunogenic profile with DNA-free, non-cellular formulation that eliminates regulatory complexity of live-cell therapies.
Lyophilized, standardized formulation with consistent potency across every batch. No patient dependency, no variability, no deep cold-chain storage requirements—ready when you need it.
The Science
Cell Factor works through a clinically designed sequence: resetting inflammatory baseline, amplifying regenerative therapies, and maintaining long-term signaling integrity.
Timeline: Days 0-30 | Clearing the Runway
The primary objective is to downregulate systemic inflammation and reverse receptor desensitization caused by chronic stress or peptide saturation. Cell Factor functions as a physiological “clearing of the runway”—calming inflammatory noise that blocks effective cellular communication.
By re-establishing homeostasis and restoring receptor sensitivity, this phase prepares the cellular environment to receive and process downstream regenerative signals, ensuring subsequent therapies are not wasted on a non-responsive system.
Timeline: Days 30-90 | Amplifying Therapy Response
Once the inflammatory baseline is reset, the protocol shifts toward active tissue repair and mitochondrial optimization. Cell Factor acts as an amplification layer—because cellular receptors have regained their sensitivity, targeted therapies act with significantly higher efficacy.
Research in Stem Cell Research & Therapy (2025) demonstrates that EVs therapy significantly increases tissue repair markers. This synergistic approach ensures biological instructions for repair are fully integrated.
Timeline: 90+ Days | Maintaining Signaling Integrity
Regeneration is not a single event but a sustained state of balance. This phase focuses on maintaining the signaling integrity established during the reset, preventing re-accumulation of inflammatory dysfunction.
Through tailored peptide support and strategic maintenance, this phase transforms the initial restorative burst into a durable platform for longevity and resilience against age-related decline.
Cell Factor delivers extracellular vesicles (EVs) and isolated signaling factors through paracrine signaling—instructing surrounding cells to repair themselves without requiring cell survival or engraftment.
Research in eLife (2015) demonstrates that paracrine communication “maximizes cellular response fidelity” and coordinates complex tissue repair processes with coordinated multi-pathway activation.
Treatment Applications
We integrate Cell Factor across our aesthetic and wellness treatments to enhance results, accelerate healing, and promote optimal regeneration.
Clinical trials demonstrate significant improvements in hair density, thickness, and growth. A 2025 systematic review of 11 clinical studies (298 patients) found:
Enhance laser treatments, microneedling, and aesthetic procedures with Cell Factor to amplify collagen production and accelerate healing. Published research shows:
Restore joint function and reduce pain through intra-articular Cell Factor injections. Clinical trials for knee osteoarthritis demonstrate:
Microneedling creates microchannels that enhance Cell Factor penetration for superior results. A 2025 clinical study confirms this combination promotes significant hair growth and skin regeneration.
Apply Cell Factor post-laser to accelerate healing, minimize downtime, and amplify results. Compatible with all laser modalities including CO2, fractional, and hair removal treatments.
Experience systemic regenerative benefits through IV infusion, subcutaneous injection, or intranasal administration. Cell Factor’s nanoscale size enables blood-brain barrier crossing and whole-body distribution.
The BHRC Approach: We use Cell Factor to optimize cellular receptor function, amplifying the efficacy of every therapy we offer. By restoring receptor sensitivity, Cell Factor transforms peptides, GLP-1 agonists, and regenerative treatments into “accelerants” with dramatically enhanced results.
Explore Your Treatment OptionsRegenerative Medicine Comparison
Both therapies harness regenerative potential, but Cell Factor delivers superior potency, consistency, and safety backed by comparative clinical research.
| Feature | Cell Factor (EVs) | PRP (Platelet-Rich Plasma) |
|---|---|---|
| Growth Factors | 400+ | 7-25 |
| Standardization | Consistent, off-the-shelf formulation | Variable, patient-dependent quality |
| Age Dependency | No—consistent potency regardless of age | Yes—decreases with patient age |
| Particle Size | 30-150 nm (nanoscale) | Larger (cellular components) |
| Tissue Penetration | Superior—crosses blood-brain barrier | Limited penetration |
| DNA Content | DNA-free (zero tumor risk) | Contains cellular DNA |
| Regulatory Classification | FDA Section 361 Tissue (not a drug) | Autologous procedure (minimal regulation) |
| Stability & Storage | Shelf-stable, lyophilized formulation | Must be prepared fresh, immediate use only |
| Preparation | Ready-to-use, no phlebotomy or centrifugation | Requires blood draw and processing |
| Treatment Time | Faster office visit | Longer (includes blood processing) |
| Hair Restoration Results | Significant improvement after single session | 5-6 sessions over 6-16 months |
| Clinical Evidence | 77 registered clinical trials; rapidly growing | Well-established (longer track record) |
Acellular vs Cellular
Both approaches leverage stem cell biology, but Cell Factor’s acellular technology eliminates the risks and limitations of living cell transplantation. Research published in Biomolecules (2024) confirms acellular therapies provide “comparable regenerative potential” with superior safety and practicality.
| Feature | Cell Factor (Acellular) | Traditional Stem Cells (Cellular) |
|---|---|---|
| DNA Content | DNA-free (zero tumor risk) | Contains living DNA (replicating cells) |
| Tumor Formation Risk | None—acellular, non-replicating | Risk of uncontrolled proliferation, especially with iPSCs |
| Immune Rejection | None—non-immunogenic | Possible rejection requiring immunosuppression |
| Cell Viability Required | No—bioactive factors work immediately | Yes—cells must survive, engraft, and differentiate |
| Storage & Availability | Shelf-stable, lyophilized off-the-shelf formulation | Complex cryopreservation; viability concerns |
| Standardization | Clinically engineered—standardized potency every batch | Variable based on donor, culture conditions |
| Manufacturing | Scalable production; lower cost | Expensive GMP facilities; complex expansion |
| Regulatory Classification | FDA Section 361 Tissue (not a drug or biologic) | Classified as drugs/biologics—extensive regulatory hurdles |
| Tissue Penetration | Superior—30-150 nm nanoscale size | Limited—cells are micron-sized (10-30 µm) |
| Blood-Brain Barrier | Can cross BBB for neuroprotection | Cannot cross BBB |
| Mechanism of Action | Paracrine signaling (secreted factors) | Engraftment, differentiation, paracrine signaling |
| Ethical Concerns | None | Potential issues with embryonic stem cells |
| Preparation Time | Ready-to-use immediately | May require weeks of culture/expansion |
| Clinical Evidence | 77 clinical trials; rapidly expanding | Extensive but mixed results; engraftment challenges |
Common Questions
Cell Factor is an acellular, DNA-free stem cell therapy that delivers the bioactive factors produced by stem cells—including over 400 growth factors and extracellular vesicles (EVs)—without transplanting living cells. This approach harnesses the regenerative power of stem cells while eliminating risks associated with cellular therapies like tumor formation and immune rejection.
Traditional stem cell therapy involves transplanting living cells that must survive, integrate, and differentiate in the body. Cell Factor delivers only the therapeutic secretome (the bioactive factors that stem cells produce) without the cells themselves. This means no DNA, no cell viability concerns, no tumor risk, and immediate bioavailability of therapeutic molecules. Research shows acellular therapies provide comparable regenerative potential with superior safety profiles.
Cell Factor holds FDA Section 361 tissue classification, which classifies it as human tissue rather than a drug or biologic. This means it is not FDA-approved as a drug, but rather regulated under human cells, tissues, and cellular and tissue-based products (HCT/P) regulations. Unlike live-cell therapies that require extensive FDA approval as drugs or biologics, Cell Factor’s acellular, DNA-free formulation qualifies for this less complex regulatory pathway. We provide full transparency about regulatory status and ensure you’re completely informed before treatment.
At BHRC, we offer Cell Factor for hair restoration, skin rejuvenation, anti-aging, joint therapy, and enhanced healing following aesthetic procedures. We integrate Cell Factor with microneedling, laser treatments, Sculptra, Botox, Emsculpt, and IV nutrient therapy to amplify results. Our medical team will assess your aesthetic goals during consultation to determine if Cell Factor is right for you.
At BHRC, we deliver Cell Factor through multiple administration routes tailored to your treatment goals: topical application (post-microneedling or laser), subcutaneous injection for facial rejuvenation, intra-articular injection for joint therapy, intravenous infusion for systemic benefits, or intranasal administration. Our providers will recommend the optimal delivery method during your consultation.
Treatment protocols at BHRC vary by application and individual goals. For hair restoration, we typically recommend a series of 6-8 treatments spaced 4-6 weeks apart, though some patients see improvement after a single session. Skin rejuvenation often shows visible benefits after one treatment but achieves optimal results with a series. Joint therapy may require 1-3 injections. Your BHRC provider will develop a personalized treatment plan during your consultation.
Clinical trials report favorable safety profiles. Because Cell Factor is acellular and DNA-free, it eliminates risks associated with living cell therapies including tumor formation, immune rejection, and unwanted cell proliferation. Most reported side effects are mild and transient (temporary redness, swelling, local irritation). Rare cases of delayed granulomatous reactions have been reported in aesthetic literature. Proper medical oversight, sterile technique, and high-quality sourcing are essential for safety.
Results vary by application. For skin rejuvenation, improvements in texture and glow may be visible within 2-4 weeks. For hair restoration, clinical studies show visible improvements beginning at 2-3 months with continued progress over several months. Joint therapy patients often report pain reduction within weeks, with continued improvement over 3-6 months. Cell Factor works by activating your body’s natural repair mechanisms, so results develop progressively as tissues regenerate.
Yes! Cell Factor is designed to enhance virtually any aesthetic or regenerative treatment. It combines synergistically with microneedling, all laser modalities, Sculptra, Botox, dermal fillers, Emsculpt, IV nutrient therapy, and more. Think of Cell Factor as a universal enhancer that amplifies your body’s healing response and optimizes treatment outcomes. This is our differentiator—we make everything better.
Cell Factor delivers 400+ growth factors compared to PRP’s 7-25, providing higher potency and diversity of bioactive molecules. Unlike PRP (which varies by patient age and health), Cell Factor offers consistent, standardized potency. Clinical studies show Cell Factor produces significant improvements after a single session, while PRP typically requires 5-6 sessions. Cell Factor is also DNA-free, requires no blood draw, and has superior tissue penetration due to nanoscale size. Both have value; your provider can help determine which is optimal for your goals.
Patient Experience
“Cell Factor treatments at BHRC have exceeded my expectations. The combination with my aesthetic procedures produced remarkable results—my skin looks rejuvenated, my hair is noticeably thicker, and I feel more vibrant. The science-backed approach and professional care give me complete confidence.”
Get Started
Schedule a consultation with our regenerative aesthetics specialists to discover how Cell Factor can enhance your treatments, accelerate healing, and unlock your body’s natural regenerative potential.
"*" indicates required fields
Or call us directly: +1 213-325-3373
Important Regulatory Disclosure: Cell Factor is classified under FDA Section 361 as human cells, tissues, and cellular and tissue-based products (HCT/P). It is regulated as human tissue, not as a drug or biologic requiring FDA approval. Cell Factor is not FDA-approved for therapeutic use and is not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary. The statements on this page have not been evaluated by the Food and Drug Administration. All clinical research cited represents peer-reviewed scientific literature and does not constitute medical claims. Cell Factor treatments at BHRC are performed by qualified healthcare professionals. A comprehensive consultation with our medical team is required to determine if Cell Factor therapy is appropriate for your aesthetic goals and individual health profile.
Experience transformative wellness and aesthetic treatments at our state-of-the-art medical spas across California, Nevada, and Arizona
